# OnCo record paper-chen-exp-hematol-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-chen-exp-hematol-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-chen-exp-hematol-oncol" ;
  schema:name "Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma"@en ;
  schema:description "Paper cited by one trial page and one treatment page, indexed on Europe PMC as PubMed record 41029877 and published in Experimental hematology & oncology; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-chen-exp-hematol-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1186/s40164-025-00710-y>, <https://pubmed.ncbi.nlm.nih.gov/41029877/>, <https://europepmc.org/article/MED/41029877> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1186/s40164-025-00710-y> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Chen W, Fu C, Fang B, et al." ;
  onco:related <https://onco.cc/drugs/zevorcabtagene-autoleucel/> ;
  onco:trials <https://onco.cc/trials/lummicar-1/> .